avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Meis1
|
ENSMUSG00000020160.12 | Meis homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Meis1 | mm10_v2_chr11_-_19018956_19018973 | 0.51 | 1.6e-03 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.5 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
1.8 | 9.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.4 | 4.3 | GO:0071846 | actin filament debranching(GO:0071846) |
1.3 | 3.8 | GO:0055130 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
1.2 | 3.6 | GO:0033624 | negative regulation of integrin activation(GO:0033624) |
0.9 | 3.8 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.9 | 3.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.8 | 2.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.8 | 12.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 3.6 | GO:0070668 | negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.6 | 1.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.6 | 1.7 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.5 | 2.2 | GO:1904430 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) negative regulation of t-circle formation(GO:1904430) |
0.5 | 2.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.5 | 1.5 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.5 | 2.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.5 | 2.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 1.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.4 | 8.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 1.6 | GO:0090095 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.4 | 1.6 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.4 | 3.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.4 | 2.0 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.4 | 3.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.4 | 1.5 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.4 | 2.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 2.2 | GO:0015867 | ATP transport(GO:0015867) |
0.3 | 1.5 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.3 | 2.3 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 2.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 1.7 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 1.1 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.3 | 0.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.3 | 1.0 | GO:0045399 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.3 | 1.0 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 1.8 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 6.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 1.2 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.2 | 3.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 1.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 1.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 1.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 2.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 0.9 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.2 | 0.4 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 2.6 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.2 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 1.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 1.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 1.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 1.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 0.8 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.2 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.4 | GO:2000642 | intralumenal vesicle formation(GO:0070676) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.8 | GO:1904587 | response to glycoprotein(GO:1904587) |
0.1 | 0.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 1.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 1.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 1.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 1.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 2.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.1 | 0.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 2.1 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.8 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 3.2 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 8.6 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.0 | 2.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.2 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) positive regulation of muscle adaptation(GO:0014744) muscle hyperplasia(GO:0014900) |
0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 3.2 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.0 | 0.3 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 1.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 1.3 | GO:0042168 | heme metabolic process(GO:0042168) |
0.0 | 4.2 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.0 | 0.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.0 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 2.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.9 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.2 | GO:0046878 | angiotensin-mediated drinking behavior(GO:0003051) tachykinin receptor signaling pathway(GO:0007217) positive regulation of synaptic transmission, cholinergic(GO:0032224) operant conditioning(GO:0035106) positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 2.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.0 | GO:0021767 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) |
0.0 | 0.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 1.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 1.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 2.8 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.0 | 0.4 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 4.2 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.0 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.0 | 0.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 4.3 | GO:0021915 | neural tube development(GO:0021915) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.9 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 1.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 5.7 | GO:0022412 | cellular process involved in reproduction in multicellular organism(GO:0022412) |
0.0 | 2.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 1.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.0 | 0.1 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 1.3 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.7 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.7 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 1.2 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.8 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.7 | 2.8 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.6 | 1.9 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.4 | 1.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 1.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.3 | 2.1 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 6.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 0.9 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.3 | 1.5 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 0.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 3.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 1.7 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 12.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 0.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.2 | 9.5 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 1.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 1.0 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 2.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.0 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 1.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 3.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 1.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 2.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.3 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 8.3 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 2.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.5 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 1.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 1.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 1.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 3.9 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 1.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 3.7 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 3.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 9.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 2.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 1.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 2.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 5.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 1.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 2.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 4.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 1.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.4 | GO:0043034 | costamere(GO:0043034) |
0.0 | 1.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 1.5 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 9.0 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.9 | 9.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.3 | 3.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.1 | 3.2 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.9 | 3.8 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.8 | 2.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.6 | 5.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.6 | 3.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 2.3 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.4 | 1.2 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.4 | 3.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 1.5 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.3 | 2.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 4.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 8.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.3 | 2.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 2.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 2.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 1.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 2.5 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 1.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.2 | 1.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.4 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 3.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 1.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 2.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 4.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 1.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.9 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 1.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.4 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 2.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 1.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 1.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 3.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 1.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 1.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 1.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 2.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 2.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.3 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.1 | 7.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 1.1 | GO:0008266 | poly(A) binding(GO:0008143) poly(U) RNA binding(GO:0008266) |
0.0 | 0.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 1.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 6.3 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 1.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 1.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 6.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 1.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 1.6 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 2.2 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 2.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 1.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 1.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 3.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 1.8 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 1.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 2.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 2.9 | GO:0051015 | actin filament binding(GO:0051015) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 6.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 6.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 7.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 8.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 3.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 3.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 10.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 2.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 2.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 1.7 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 4.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 6.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.8 | PID ATM PATHWAY | ATM pathway |
0.0 | 1.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 1.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 9.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 6.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 2.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 9.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 2.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 2.9 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 4.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 2.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 1.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 1.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 1.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 1.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 6.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 2.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 1.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.8 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 2.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 1.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |